Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 10/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | GSK3A | P49840 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24939789 | 0.90 | HCAR2 (0.46) | HCAR2MEN1KMT2AATMSMN1; SMN2 | |
| SCHEMBL24939785 | 0.82 | MEN1 (0.47) | HCAR2MEN1KMT2AATMSMN1; SMN2 | |
| SCHEMBL24939793 | 0.79 | TSHR (0.37) | SMN1; SMN2MAPT | |
| SCHEMBL24938802 | 0.75 | HCAR2 (0.49) | HCAR2MEN1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL24939685 | 0.74 | ALDH1A1 (0.47) | MEN1KMT2AMAPTNPSR1 | |
| SCHEMBL26620226 | 0.69 | HCAR2 (0.49) | HCAR2MEN1KMT2AATMSMN1; SMN2 | |
| SCHEMBL19029776 | 0.69 | HCAR2 (0.49) | HCAR2MEN1KMT2AATMSMN1; SMN2 | |
| SCHEMBL19029793 | 0.69 | HCAR2 (0.49) | HCAR2MEN1KMT2AATMSMN1; SMN2 | |
| SCHEMBL24939800 | 0.68 | MEN1 (0.46) | HCAR2MEN1KMT2AATMSMN1; SMN2 | |
| SCHEMBL24939794 | 0.68 | TSHR (0.38) | SMN1; SMN2MAPTGSK3AGSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230022129-A1 | RESIST MATERIAL AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230022129-A1 | RESIST MATERIAL AND PATTERNING PROCESS | GFER, LBR, PCNA | HCAR2 601/4885MEN1 1589/4885KMT2A 1415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.